Dr. Nancy Whiting joined Seattle Genetics in March 2007, and was promoted to Executive Vice President, Corporate Strategy, Alliances and Communications in October2020. She previously served as Executive Vice President, Late Stage Development, Senior Vice President, Development and Medical Affairs, Elliott Bay Site Head,and Senior Medical Director and Head of Experimental Medicine. In her current position, Nancy has the broad remit of corporate strategy and planning, alliances and strategic partnerships, investor relations and corporate communications.Prior to transitioning to the pharmaceutical industry, Dr. Whiting practiced as a Clinical Oncology Pharmacist at the Seattle Cancer Care Alliance. Dr. Whiting completed her undergraduate training at the University of British Columbia and received her PharmD from the University of Washington. She also completed a residency in clinical pharmacy practice at Vancouver General Hospital. Dr. Whiting is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the European Society of Medical Oncology. She serves on the Board of Directors for the Life Science Washington trade association.